To further investigate the tumorigenic potential of STIP1 in ESCC cells, we employed a CDX model in which STIP1‐silenced cells were subcutaneously inoculated into immunocompromised mice. This evidence concerns the gene STIP1 and esophageal squamous cell carcinoma.